{"url_path":"/sec/allo/8-k/2026-06-22/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1737287/0001628280-26-044618-index.html","accession_number":"0001628280-26-044618","cik":"0001737287","ticker":"ALLO","issuer_name":"Allogene Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1737287/0001628280-26-044618-index.html","primary_entity_key":"0001737287","primary_entity_name":"Allogene Therapeutics, Inc."},"word_count":494,"has_tables":true,"body_markdown":"Item 5.07    Submission of Matters to a Vote of Security Holders.\n\nOn June 18, 2026, Allogene Therapeutics, Inc. (the \"Company\") held its 2026 Annual Meeting of Stockholders (the \"Annual Meeting\"). At the Annual Meeting, the stockholders of the Company voted on five proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 30, 2026 (the \"Proxy Statement\"). As of April 20, 2026, the record date for the Annual Meeting, 345,024,351 shares of common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders at the Annual Meeting is set forth below.\n\nProposal 1. Election of Directors\n\nThe Company’s stockholders elected the three persons listed below as Class II Directors, each to serve until the Company’s 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The final voting results are as follows:\n\nVotes ForVotes WithheldBroker Non-Votes\n\nDeborah Messemer202,325,76726,099,64154,299,010\n\nVicki Sato, Ph.D.202,326,29926,099,10954,299,010\n\nOwen Witte, M.D.189,310,48439,114,92454,299,010\n\nProposal 2. Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers\n\nThe Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement. The final voting results are as follows:\n\nVotes ForVotes AgainstAbstentionsBroker Non-Votes\n\n213,098,16711,951,2563,375,98554,299,010\n\nProposal 3. Approval, on an Advisory Basis, Say-On-Pay Vote Frequency\n\nThe Company’s stockholders approved, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. The final voting results are as follows:\n\n1 Year2 Years3 YearsAbstentionsBroker Non-Votes\n\n224,054,368228,313757,9923,384,73554,299,010\n\nIn light of and consistent with the votes cast with respect to such proposal, the Board of Directors of the Company (the “Board”) has determined to hold future say-on-pay votes every year until the next required non-binding advisory vote on the frequency of future say-on-pay votes, which will be held no later than the 2032 Annual Meeting of Stockholders.\n\nProposal 4. Amendment to Amended and Restated Certificate of Incorporation To Increase the Number of Authorized Shares\n\nThe Company’s stockholders approved an amendment (the \"Amendment\") to the Company's Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000. The final voting results are as follows:\n\nVotes ForVotes AgainstAbstentionsBroker Non-Votes\n\n221,767,9956,535,254122,15954,299,010\n\nThe Amendment was filed with the Secretary of State of the State of Delaware on June 18, 2026 and effective as of such date. A copy of the Amendment is filed as Exhibit 3.1 to this Current Report on Form 8-K.\n\nProposal 5. Ratification of the Selection of Independent Registered Public Accounting Firm\n\nThe Company’s stockholders ratified the selection by the Audit Committee of the Board of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results are as follows:\n\nVotes ForVotes AgainstAbstentionsBroker Non-Votes\n\n282,022,884503,156198,3780"}